OpTek CTO Duane Dinke explains how laser processing optimizes optical fiber evanescence for next-gen biomedical diagnostics ...

Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion ...

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...

Orchestra BioMed Holdings ( ($OBIO) ) just unveiled an update. On October 28, 2025, Orchestra BioMed Holdings announced a new strategic agreement ...

New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreementTerumo to pay a ...

Drug-releasing medical devices have revolutionized therapeutic delivery by integrating pharmacological function directly into biomedical implants. A ...

From ingestible pills that track gut health to smart bandages that can autonomously provide required treatment to wounds, ...

Lifecore Biomedical ( ($LFCR) ) has shared an update. On October 29, 2025, Lifecore Biomedical held its annual meeting of stockholders, where ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...

This advancement is detailed in the journal Device and written by a team led by biomedical engineer Jung Seung Lee at ...

Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to ...

PhysioBiometrics, an affiliate of AGE-WELL network, has introduced Heel2Toe, a wearable device aimed at improving gait in ...